| Literature DB >> 25402683 |
Jose Pedro Friedmann Angeli1, Manuela Schneider2, Bettina Proneth1, Yulia Y Tyurina3, Vladimir A Tyurin3, Victoria J Hammond4, Nadja Herbach5, Michaela Aichler6, Axel Walch6, Elke Eggenhofer7, Devaraj Basavarajappa8, Olof Rådmark8, Sho Kobayashi9, Tobias Seibt1, Heike Beck10, Frauke Neff6, Irene Esposito11, Rüdiger Wanke5, Heidi Förster1, Olena Yefremova1, Marc Heinrichmeyer1, Georg W Bornkamm12, Edward K Geissler7, Stephen B Thomas13, Brent R Stockwell13, Valerie B O'Donnell4, Valerian E Kagan3, Joel A Schick1, Marcus Conrad1.
Abstract
Ferroptosis is a non-apoptotic form of cell death induced by small molecules in specific tumour types, and in engineered cells overexpressing oncogenic RAS. Yet, its relevance in non-transformed cells and tissues is unexplored and remains enigmatic. Here, we provide direct genetic evidence that the knockout of glutathione peroxidase 4 (Gpx4) causes cell death in a pathologically relevant form of ferroptosis. Using inducible Gpx4(-/-) mice, we elucidate an essential role for the glutathione/Gpx4 axis in preventing lipid-oxidation-induced acute renal failure and associated death. We furthermore systematically evaluated a library of small molecules for possible ferroptosis inhibitors, leading to the discovery of a potent spiroquinoxalinamine derivative called Liproxstatin-1, which is able to suppress ferroptosis in cells, in Gpx4(-/-) mice, and in a pre-clinical model of ischaemia/reperfusion-induced hepatic damage. In sum, we demonstrate that ferroptosis is a pervasive and dynamic form of cell death, which, when impeded, promises substantial cytoprotection.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25402683 PMCID: PMC4894846 DOI: 10.1038/ncb3064
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824